Viral Vector and Plasmid Manufacturing Market Growth – at a CAGR of 14.3% During Forecast Period 2020-2027

Rapid advancements in manufacturing viral vector and plasma DNA and rising prevalence of various chronic diseases and genetic disorders are some key factors expected to drive global market growth during the forecast period  

Emergen Research has recently published its latest report titled, “Viral Vector and Plasmid Manufacturing Market By Vector Type (Retrovirus, Adenovirus, Others), By Workflow (Upstream, Downstream), By Disease (Cancer, Genetic Disorders, Others), By Application (Gene Therapy, Retailers) and By End Use, and Region Forecasts to 2027”

According to Emergen Research, the global viral vector and plasmid manufacturing market size was USD 358.4 million in 2019 and is expected to reach USD 1.12 billion in 2027 and register a revenue CAGR of 14.3% during the forecast period, 2020-2027.

Market Dynamics: 

Viral vector and plasmid DNA are crucial tools used for transferring genetic materials into the cells. Various types of vectors such as adenovirus, lentivirus, adeno-associated virus, herpes simplex virus are used in molecular biology research, gene therapy and development of novel vaccines. Factors such as increasing prevalence of genetic disorders and infectious diseases across the globe, high focus on developing and manufacturing novel drugs, rising demand for viral vector-based vaccines are expected to drive global market revenue growth over the forecast period. In addition, high usage of plasmid DNA for developing advanced genetic therapies, rising number of product approvals, favorable government initiatives, and increasing investments in R&D activities are expected to further fuel market growth during the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/14

However, high cost of gene therapies, requirement of high capital income, dearth of skilled healthcare professionals, and complex procedures for the large-scale production of viral vector and plasma DNA are some key factors that can restrain market growth during the forecast period. 

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Research Institutes Segment Register Rapid Revenue Growth: 

The research institutes segment is expected to register rapid revenue growth over the forecast period owing to increasing number of research institutes across the globe, rising gene therapy research-based activities, favorable government support, and growing funds by various public and private organizations.  

Adenovirus Segment to Account for Largest Revenue Share:

The adenovirus segment is expected to account for largest revenue share during the forecast period. This can be attributed to factors such as rising prevalence of various chronic diseases, high usage in clinical trials, and increasing investments in research and development activities. Adenovirus vectors are widely used in vaccines due to its capability of inducing strong hormonal and T-cell responses. 

Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/14

North America to Lead in Terms of Revenue Share: 

North America is expected to account for largest revenue share in the global market over the forecast period owing to high prevalence of chronic and genetic diseases, rapid technological advancements, presence of well-developed healthcare and research facilities, and rising number of research centers, institutes, and pharmaceutical companies. Other factors such as increasing number of approvals for advanced therapies, growing investments in research and development activities, and increasing investments for introducing advanced viral vector-based therapies are expected to drive North America market revenue growth during the forecast period. 

Major Companies in the Market Include:

  • Brammer Bio
  • Cobra Biologics
  • Cell and Gene Therapy Catapult
  • FinVector Vision Therapies
  • Fujifilm Diosynth Biotechnologies
  • MassBiologics
  • SIRION Biotech
  • Merck KGaA Inc.
  • Thermo Fisher Scientific
  • Unique NV

For the purpose of this report, Emergen Research has segmented into the global viral vector and plasmid manufacturing market on the basis of vector type, workflow, disease, application, end-user, and region:

Vector Type Outlook (Revenue, USD Billion; 2017-2027)

  • Adenovirus
  • Retrovirus
  • Plasmid DNA
  • AAV
  • Lentivirus
  • Others

Workflow Outlook (Revenue, USD Billion; 2017-2027)

  • Upstream Processing
  • Downstream Processing

Disease Outlook (Revenue, USD Billion; 2017-2027)

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Antisense & RNAi
  • Gene Therapy
  • Cell Therapy
  • Vaccinology

End Use Outlook (Revenue: USD Billion; 2017-2027)

  • Pharmaceutical and Biopharmaceutical Companies
  • Research Institutes

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/viral-vector-and-plasmid-manufacturing-market

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • BENELUX
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Latest Published Reports by Emergen Research:

Construction Market By Type (Building Construction, Heavy and Civil Engineering Construction, Specialty Trade Contractors, Land Planning and Development), By Building (Residential Building, Non-Residential Building), By Construction Machinery, By End-Use, and By Region Forecast to 2028

Insulating Glass Window Market By Sealant Type (Polysulfide, Hot-melt Butyl, Polyurethane, Silicone), By Spacer Type (Aluminum Box, Stainless Steel Box, Non-metal spacers), By End-use (Commercial, Residential), and By Region Forecast to 2028

Logistics & Supply Chain Industry Market By Transportation Mode (Railways, Roadways, Airways, Waterways), By Application (Transportation, Warehousing, Sourcing & Procurement), By Industry Vertical (Manufacturing, Retail, Healthcare, Aerospace, BFSI, Government & Public Utilities, Media & Entertainment, Food & Beverages), and By Region Forecast to 2028

Structured Cabling Market By Solution (Service, Product, Software), By Cable Type (Category 6, Category 5E, Category 6A, Others), By End-Use (IT & Telecommunication, Residential & Commercial, Government & Education, Transportation, Industrial, Others) and By Region

Cold Storage Construction Market By Application (Biopharmaceutical products, Perishable food), By Storage Type (Bulk stores, Production stores), By Cold Storage Warehouse Type (Refrigerated containers), and By Region, Forecast to 2027

Construction Equipment Rental Market By Equipment Type (Earthmoving, Material Handling, Road Building, Concrete), By Product Type (Excavators, Cranes, Backhoes, Crawler Dozers, Concrete Pumps), By Application (Rea-Estate, Commercial Estate, Transport Power & Energy Infrastructure, Others), and By Region

Powered Agriculture Equipment Market By Type (Combine Harvesters, Tractors, Soil Preparation & Cultivation Equipment), By Next generation equipment (Agricultural Unmanned Aerial Vehicles, Driverless Tractors, Electric Tractors), and By Region, Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@ https://www.emergenresearch.com/press-release/global-viral-vector-and-plasmid-manufacturing-market

Back to news